The study highlights that combining the DecisionDx-UM test with PRAME expression is superior to standard mutation analysis. And for a patient who's just been diagnosed with uveal melanoma, what does ...

Heather Quintana Suchan, a mother living with stage 4 lung cancer, has continued working in the music industry throughout her diagnosis. With 15 years of experience, particularly in the growing ...

The Food and Drug Administration (FDA) has approved Calquence (acalabrutinib) tablets and capsules in combination with Venclexta (venetoclax) for adults with chronic lymphocytic leukemia (CLL) or ...

Dr. Shaun P. McKenzie discusses bile duct cancer challenges and why awareness and specialized care help patients get diagnosed earlier and live longer.

Workforce shortages do not affect all patients equally. Rural communities face the greatest gaps in oncology access, with higher cancer mortality rates and longer travel times for treatment. Patients ...

Resistant cells demonstrated global decreases in DNA accessibility with localized opening at resistance-driving loci, indicating non-mutational epigenetic reprogramming rather than canonical oncogenic ...

Overall, the study found that app-based self-acupressure was safe and associated with sustained reductions in cancer-related ...

Median’s eyonis LCS is being evaluated as a tool to help assess the likelihood that a lung lesion detected on low-dose CT is malignant, Oran Muduroglu, founder and CEO of Coeus Health, said in an ...

Platinum-based chemotherapy produced delayed, severe GI toxicity and functional decline; clinician reassurance that symptoms were expected and hydration-focused support improved adherence. Looking ...

Marked underrepresentation of non-White patients persists in ovarian cancer trials, and incomplete race/ethnicity reporting ...

PLT012 received FDA fast track status for liver cancer, with an ongoing trial evaluating safety and early activity of the CD36-targeting immunotherapy.

As treatment options for acute myeloid leukemia (AML) evolve, new therapies could change the patient experience around allogeneic stem cell transplant. CURE sat down with Dr. Gwen Nichols, chief ...